Financial Performance - Net profit attributable to shareholders for Q1 2021 was CNY 48,996,742.62, down 3.36% year-on-year[8]. - Operating revenue for Q1 2021 was CNY 240,002,745.49, a decline of 4.03% compared to the same period last year[8]. - Total revenue for Q1 2021 was CNY 240,002,745.49, a decrease of 4.32% compared to CNY 250,080,385.52 in Q1 2020[34]. - Total operating costs for Q1 2021 were CNY 189,848,535.95, down from CNY 197,544,536.98 in Q1 2020, reflecting a reduction of 3.54%[34]. - Net profit for Q1 2021 was CNY 48,753,251.97, slightly down from CNY 48,845,492.00 in Q1 2020, indicating a decrease of 0.19%[37]. - The company's operating revenue for Q1 2021 was ¥218,606,945.54, a decrease of 8.4% compared to ¥239,516,884.13 in Q1 2020[40]. - The net profit for Q1 2021 was ¥56,888,780.80, representing an increase of 4.8% from ¥54,331,741.80 in Q1 2020[43]. - The total comprehensive income for Q1 2021 was ¥56,888,780.80, up from ¥54,331,741.80 in Q1 2020[43]. Cash Flow - Net cash flow from operating activities was negative CNY 41,095,004.95, a decrease of 136.31% year-on-year[8]. - Cash inflow from operating activities was ¥271,590,434.81 in Q1 2021, down from ¥398,296,427.09 in Q1 2020, a decline of 31.9%[44]. - The company reported a net cash inflow from sales of goods and services of ¥246,152,536.75 in Q1 2021, down from ¥387,083,947.84 in Q1 2020[44]. - The company recorded a tax expense of ¥10,104,441.03 in Q1 2021, compared to ¥9,587,954.44 in Q1 2020, an increase of 5.4%[40]. - The company paid 63,551,846.32 RMB to employees, an increase from 51,739,186.00 RMB in the previous year, indicating higher personnel costs[48]. - The cash flow from operating activities showed a net outflow of 35,303,400.67 RMB, contrasting with a net inflow in the previous year, highlighting operational challenges[48]. Assets and Liabilities - Total assets at the end of Q1 2021 were CNY 2,857,658,840.31, a decrease of 0.07% compared to the end of the previous year[8]. - The total current assets as of March 31, 2021, were ¥1,823,393,726.49, down from ¥1,865,074,961.71 at the end of 2020, indicating a decrease of about 2.2%[23]. - The total liabilities decreased to ¥429,084,804.58 as of March 31, 2021, from ¥480,245,660.39 at the end of 2020, a reduction of about 10.6%[29]. - The total equity attributable to shareholders increased to ¥2,331,628,062.90 as of March 31, 2021, up from ¥2,282,816,377.57 at the end of 2020, representing an increase of approximately 2.1%[29]. - The company's total assets amounted to CNY 2,614,244,212.39, a slight decrease from CNY 2,618,403,145.67 in the previous period[34]. - Current liabilities totaled CNY 335,486,030.59, down 15.39% from CNY 396,533,744.67 in the previous period[32]. - Non-current assets increased to CNY 989,312,340.73 from CNY 941,470,371.41, representing a growth of 5.73%[32]. Shareholder Information - The company’s major shareholder, Jiangsu Yuyue Technology Development Co., Ltd., holds 26.72% of the shares[11]. - Midea Group acquired 24.09% of the company's total shares, changing the controlling shareholder[18]. - The number of shareholders at the end of the reporting period was 41,697[11]. Government Support - The company received government subsidies amounting to CNY 1,006,371.80 during the reporting period[8].
万东医疗(600055) - 2021 Q1 - 季度财报